ASX:TNY
ASX:TNYInteractive Media and Services

3 ASX Penny Stocks With Market Caps Under A$200M

Australian shares are poised for a rebound, with futures indicating a positive open as local investors take cues from Wall Street's recent gains. For those interested in exploring smaller or newer companies, penny stocks—despite their somewhat dated terminology—continue to offer intriguing opportunities. By focusing on firms with solid financial foundations and potential for growth, investors may uncover valuable prospects within the realm of penny stocks.
ASX:DRO
ASX:DROAerospace & Defense

Why DroneShield (ASX:DRO) Is Down 7.7% After Securing a Record A$25 Million Latin America Deal

DroneShield has announced it secured a record A$25 million contract with a government customer in Latin America, marking its largest order to date for counter-drone and electronic warfare equipment, with deliveries scheduled across late 2025 and early 2026. This milestone reflects rapid adoption of DroneShield’s technology in new regions and signals growing institutional demand for advanced counter-UAS solutions worldwide. We'll examine how capturing its largest-ever government order in...
ASX:AGL
ASX:AGLIntegrated Utilities

AGL Energy (ASX:AGL) Valuation Spotlight as Solar Sharer Programme Sparks Dividend and Margin Concerns

AGL Energy (ASX:AGL) is in the spotlight after the Australian government introduced its Solar Sharer programme, which mandates three hours of free daily electricity for consumers from July 2026. Investors are weighing how these regulatory changes could affect AGL’s earnings and dividend outlook. See our latest analysis for AGL Energy. Following the Solar Sharer announcement, AGL Energy’s shares slipped further, capping off a tough year marked by regulatory uncertainty and sector pressure...
ASX:WGX
ASX:WGXMetals and Mining

Will New Multi-Year Production Guidance and Record Gold Prices Change Westgold Resources' (ASX:WGX) Narrative

Westgold Resources Limited recently issued new multi-year production guidance through fiscal 2028 and reported operational results for the quarter ended September 30, 2025, including gold sales of 94,913 ounces at a record price of $5,296 per ounce. The company's updated outlook highlights expectations for increasing gold production levels and all-in sustaining costs, offering a clear indication of operational direction amid evolving market conditions. We'll explore how Westgold's outlook...
ASX:QBE
ASX:QBEInsurance

3 ASX Dividend Stocks Yielding Up To 4.1%

The Australian market has faced a challenging week, with the ASX200 slipping into negative territory amid a cautious mood influenced by economic concerns both locally and from the US. As investors navigate these turbulent times, dividend stocks can offer some stability and income potential, making them an attractive option for those seeking to balance risk in their portfolios.
ASX:JMS
ASX:JMSMetals and Mining

Aims Property Securities Fund And 2 Other ASX Penny Stocks To Watch

The Australian market has recently faced a challenging period, with the ASX200 experiencing declines amid negative sentiment from the US and domestic economic concerns. Despite these broader market conditions, there are still opportunities for investors willing to explore beyond well-known stocks. Penny stocks, often associated with smaller or newer companies, continue to offer intriguing prospects for growth at lower price points. In this article, we examine three penny stocks that stand out...
ASX:CUV
ASX:CUVBiotechs

How Investors Are Reacting To Clinuvel Pharmaceuticals (ASX:CUV) SEC Filing Delays Amid US Government Disruptions

Clinuvel Pharmaceuticals announced that delays in the U.S. Federal government's operations have affected the review and approval timelines for its registration statements submitted to the SEC. This development highlights how external regulatory factors, such as government shutdowns, can meaningfully influence timelines and operational certainty for international biopharmaceutical companies. We’ll explore how these government-related approval delays could impact Clinuvel’s growth outlook and...
ASX:CSL
ASX:CSLBiotechs

A Closer Look at CSL (ASX:CSL) Valuation Following Capital Markets Day and Guidance Downgrade

CSL (ASX:CSL) is in the spotlight as it hosts its Capital Markets Day event, presenting strategic priorities and growth initiatives for investors. The timing comes after a recent guidance downgrade and market volatility. See our latest analysis for CSL. Despite promising long-term trends in core plasma and vaccine markets, CSL’s share price return has slid sharply this year, with a 30-day drop of 14.3% and a year-to-date fall of 37.3%. After briefly rallying on hopes for operational...
ASX:WBC
ASX:WBCBanks

Westpac (ASX:WBC) Dividend Announcement Prompts Fresh Look at Valuation and Shareholder Returns

Westpac Banking (ASX:WBC) just declared an ordinary dividend of A$0.77 per share for the six months to September 2025. This offers investors a fresh look at shareholder returns and reflects the bank’s confidence in its outlook. See our latest analysis for Westpac Banking. Westpac’s recent dividend news landed just as the bank’s shares have been showing renewed momentum, with a 24.07% year-to-date share price return and an impressive 30.78% total shareholder return over the past year. Compared...